Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Net Margin (2016 - 2026)

Ekso Bionics Holdings has reported Net Margin over the past 13 years, most recently at 148.54% for Q4 2025.

  • On a quarterly basis, Net Margin fell 8148.0% to 148.54% in Q4 2025 year-over-year; TTM through Dec 2025 was 106.54%, a 4333.0% decrease, with the full-year FY2025 number at 106.53%, down 4332.0% from a year prior.
  • Net Margin reached 148.54% in Q4 2025 per EKSO's latest filing, down from 33.59% in the prior quarter.
  • The five-year high for Net Margin was 33.59% in Q3 2025, with the low at 196.4% in Q2 2025.
  • The 5-year median for Net Margin is 98.16% (2025), against an average of 105.53%.
  • Peak YoY movement for Net Margin: skyrocketed 16352bps in 2021, then plummeted -14759bps in 2025.
  • Tracing EKSO's Net Margin over 5 years: stood at 112.56% in 2021, then fell by -13bps to 126.78% in 2022, then surged by 48bps to 66.31% in 2023, then decreased by -1bps to 67.05% in 2024, then tumbled by -122bps to 148.54% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 148.54%, 33.59%, and 196.4% for Q4 2025, Q3 2025, and Q2 2025 respectively.